Urinary concentrations of benzophenone-3 and reproductive outcomes among women undergoing infertility treatment with assisted reproductive technologies.


Journal

The Science of the total environment
ISSN: 1879-1026
Titre abrégé: Sci Total Environ
Pays: Netherlands
ID NLM: 0330500

Informations de publication

Date de publication:
15 Aug 2019
Historique:
received: 14 12 2018
revised: 30 04 2019
accepted: 30 04 2019
pubmed: 12 5 2019
medline: 14 8 2019
entrez: 12 5 2019
Statut: ppublish

Résumé

Benzophenone-3 is used in a variety of cosmetic products as a sunscreen, and has shown weak estrogenic and antiandrogenic activity in animal and in vitro studies. Few studies have evaluated whether benzophenone-3 is associated with reproductive outcomes among women. We studied 304 women undergoing infertility treatment (2007-2017) in the prospective Environment and Reproductive Health cohort study and who underwent 449 treatment cycles (n = 788 urines). Generalized linear mixed models were used with random intercepts to account for multiple cycles, and adjusting for confounders including physical activity. Analyses were also stratified by self-reported moderate/heavy outdoor work. The cycle-specific median (IQR) urinary benzophenone-3 concentration was 147 (58, 462) μg/L, and 98% samples had detectable concentrations. Self-reported sunscreen use, physical activity, and time spent on moderate/heavy outdoor work were positively associated with urinary benzophenone-3. Adjusted probabilities of implantation, clinical pregnancy and live birth were higher in increasing quartiles of benzophenone-3, but these associations were restricted to women who reported spending time outdoors performing moderate/heavy work. Specifically, among these women, those in the highest quartile of benzophenone-3 concentrations had 51% higher implantation (p,trend = 0.02), 68% higher clinical pregnancy (p,trend = 0.01) and 75% higher live birth (p,trend = 0.02) adjusted probabilities than women in the lowest quartile. Benzophenone-3 was unrelated to these outcomes among women who did not report doing moderate/heavy work outdoors. These results confirm that sunscreen use is a source of benzophenone-3 exposure, and show positive associations between benzophenone-3 and pregnancy outcomes, especially among women who reported engaging in outdoor work. Since these associations may be subject to important residual confounding by lifestyle factors, further research is needed to confirm these novel results in other populations, and to investigate whether other factors may be affecting the relation of benzophenone-3 with fertility and other health outcomes.

Identifiants

pubmed: 31077917
pii: S0048-9697(19)32010-8
doi: 10.1016/j.scitotenv.2019.04.452
pmc: PMC6550292
mid: NIHMS1529437
pii:
doi:

Substances chimiques

Benzophenones 0
Sunscreening Agents 0
oxybenzone 95OOS7VE0Y

Types de publication

Journal Article

Langues

eng

Pagination

390-398

Subventions

Organisme : NIEHS NIH HHS
ID : P30 ES000002
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES009718
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES022955
Pays : United States

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Références

Br J Clin Pharmacol. 1999 Oct;48(4):635-7
pubmed: 10583038
Photodermatol Photoimmunol Photomed. 2000 Aug;16(4):147-55
pubmed: 11019938
Contact Dermatitis. 2002 Jun;46(6):348-51
pubmed: 12190623
Toxic Rep Ser. 1992 Oct;21:1-E14
pubmed: 12209185
Toxicology. 2004 Dec 1;205(1-2):113-22
pubmed: 15458796
Toxicol Sci. 2005 Feb;83(2):264-72
pubmed: 15537743
Am J Clin Nutr. 2004 Dec;80(6 Suppl):1678S-88S
pubmed: 15585788
Toxicol Appl Pharmacol. 2005 Feb 15;203(1):9-17
pubmed: 15694459
Anal Chem. 2005 Aug 15;77(16):5407-13
pubmed: 16097788
Environ Health Perspect. 2008 Jul;116(7):893-7
pubmed: 18629311
Environ Health Perspect. 2008 Jul;116(7):A306
pubmed: 18629341
Environ Health Perspect. 2008 Aug;116(8):1092-7
pubmed: 18709157
Photodermatol Photoimmunol Photomed. 2008 Aug;24(4):164-74
pubmed: 18717957
Int J Androl. 2010 Apr;33(2):385-93
pubmed: 20002217
Reprod Toxicol. 2010 Dec;30(4):532-9
pubmed: 20656017
Environ Health Perspect. 2012 Mar;120(3):464-70
pubmed: 21900077
Int J Androl. 2012 Jun;35(3):424-36
pubmed: 22612478
Environ Health Perspect. 2012 Nov;120(11):1538-43
pubmed: 22721761
Environ Sci Technol. 2013 Apr 2;47(7):3439-47
pubmed: 23469879
Reprod Biol Endocrinol. 2013 Jul 16;11:66
pubmed: 23870423
Environ Sci Technol. 2014 Apr 1;48(7):4103-9
pubmed: 24588714
Curr Opin Obstet Gynecol. 2014 Jun;26(3):181-5
pubmed: 24752004
Environ Int. 2014 Sep;70:143-57
pubmed: 24934855
Adv Exp Med Biol. 2014;810:1-16
pubmed: 25207357
Am J Epidemiol. 2014 Dec 15;180(12):1168-75
pubmed: 25395025
Toxicol Appl Pharmacol. 2015 Jan 15;282(2):119-28
pubmed: 25528284
Hum Reprod Update. 2015 Jul-Aug;21(4):411-26
pubmed: 25801630
Environ Toxicol Chem. 2015 Dec;34(12):2833-40
pubmed: 26118430
Curr Epidemiol Rep. 2015 Jun;2(2):131-142
pubmed: 26185745
Hum Reprod. 2015 Sep;30(9):2120-8
pubmed: 26209788
Environ Res. 2015 Oct;142:563-7
pubmed: 26298557
Sci Total Environ. 2016 Feb 1;543(Pt A):28-36
pubmed: 26575635
Fertil Steril. 2016 Mar;105(3):714-721
pubmed: 26654974
J Expo Sci Environ Epidemiol. 2017 May;27(3):326-332
pubmed: 27168391
Reprod Toxicol. 2016 Oct;65:104-112
pubmed: 27423903
Environ Res. 2016 Nov;151:30-37
pubmed: 27448730
Am J Clin Nutr. 2016 Sep;104(3):729-35
pubmed: 27465382
Reprod Biomed Online. 2016 Oct;33(4):513-521
pubmed: 27474489
Environ Res. 2016 Nov;151:595-600
pubmed: 27591839
Facts Views Vis Obgyn. 2016 Jun 27;8(2):75-83
pubmed: 27909564
Dermatoendocrinol. 2016 Oct 19;8(1):e1248325
pubmed: 27942349
Ann Intern Med. 2017 Aug 15;167(4):268-274
pubmed: 28693043
Reprod Biol Endocrinol. 2018 Feb 09;16(1):13
pubmed: 29426322
Hum Reprod Open. 2018 Feb;2018(2):
pubmed: 29888739
Environ Int. 2018 Nov;120:137-144
pubmed: 30092451
Int J Epidemiol. 1994 Oct;23(5):991-9
pubmed: 7860180

Auteurs

Lidia Mínguez-Alarcón (L)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, United States of America. Electronic address: lminguez@hsph.harvard.edu.

Yu-Han Chiu (YH)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, United States of America; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America.

Feiby L Nassan (FL)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, United States of America; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, United States of America.

Paige L Williams (PL)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, United States of America.

John Petrozza (J)

Division of Reproductive Medicine and IVF, Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, United States of America.

Jennifer B Ford (JB)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, United States of America.

Antonia M Calafat (AM)

National Center for Environmental Health, Centers for Disease Control and Prevention, Atlanta, GA, United States of America.

Russ Hauser (R)

Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, United States of America; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America; Vincent Obstetrics and Gynecology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States of America.

Jorge E Chavarro (JE)

Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, United States of America; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, United States of America; Channing Laboratory, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, United States of America.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH